17.10.2016
- Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...
04.10.2016
- Continuing its recent spending spree, Allergan has bought Akarna Therapeutics for $50 million in cash. The privately held biopharmaceutical company, which has dual headquarters in...
21.09.2016
- In its second acquisition announced this month, Allergan has agreed to pay nearly $1.7 billion for Tobira Therapeutics, a US clinical-stage biopharmaceutical company that develops...
08.09.2016
- Allergan has acquired “substantially all” of the assets of RetroSense Therapeutics, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to...
09.08.2016
- Israel’s Teva Pharmaceutical Industries has agreed to buy Allergan’s generics distributer Anda for $500 million. Anda distributes generic, branded, specialty and over-the-counter...
12.05.2016
- The good old days are gone — at least with regard to simplicity in business life. This is particularly true for life sciences companies affected by trends increasing the complexity...
11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
12.04.2016
- Allergan Pharmaceuticals International, a wholly owned subsidiary of Ireland-based Allergan, has entered a definitive agreement with British biotech firm Heptares to license...
